Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06842472
What this trial is testing

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Not applicableLooking for participantsNCT06061705
What this trial is testing

Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Fondation Hôpital Saint-Joseph 100
Testing effectiveness (Phase 2)Study completedNCT00002937
What this trial is testing

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT00815295
What this trial is testing

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Who this might be right for
Squamous Cell Cancer
Duke University 31
Testing effectiveness (Phase 2)Ended earlyNCT00006001
What this trial is testing

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00519077
What this trial is testing

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
University of Chicago 44
Testing effectiveness (Phase 2)Study completedNCT00003688
What this trial is testing

Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia

Who this might be right for
Gestational Trophoblastic Tumor
Gynecologic Oncology Group
Not applicableLooking for participantsNCT06197776
What this trial is testing

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Who this might be right for
Multi-omics TechniqueNasopharyngeal CarcinomaRecurrent and Metastatic Nasopharyngeal Carcinoma+1 more
Sun Yat-sen University 50
Large-scale testing (Phase 3)WithdrawnNCT03342352
What this trial is testing

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Who this might be right for
Head and Neck Cancer
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT02535338
What this trial is testing

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT02339558
What this trial is testing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Nonkeratinizing CarcinomaRecurrent Nasopharynx CarcinomaStage III Nasopharyngeal Carcinoma AJCC v7+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT05661578
What this trial is testing

Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

Who this might be right for
PD-L1-selected Solid Tumors
Hoffmann-La Roche 64
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Testing effectiveness (Phase 2)Ended earlyNCT00323063
What this trial is testing

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 49
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00083031
What this trial is testing

Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 57
Next Page